PRESS RELEASE ARCHIVE

Press Releases
10. Jul 2013

Pioneering breakthrough in the chemical synthesis of Interferon β-1a

Bubendorf/Basel, Switzerland and Kyoto, Japan July 10, 2013 - GlyTech, Inc. (Kyoto, Japan) and...

more
25. Apr 2013

Bachem switching from IFRS to Swiss GAAP FER

Bubendorf/Basel, April 25, 2013 – The Board of Directors of Bachem Holding AG (SIX: BANB) passed a...

more
03. Apr 2013

Bachem and Axon Neuroscience sign contract for finished dosage forms of peptide-protein conjugate

Bubendorf/Basel, Switzerland and Bratislava, SlovakiaBachem (SIX: BANB) and Axon Neuroscience SE...

more
15. Mar 2013

2012 financial year: Bachem clearly tops prior-year results at all levels

Bachem Group (SIX: BANB) generated sales of 157.3 million CHF in the 2012 financial year in the...

more
24. Aug 2012

Bachem well on track in a challenging market

Bachem Group (SIX: BANB) reported sales of 76.2 million CHF for the first half of 2012. Sales were...

more
16. Mar 2012

Bachem confirms upward trend in its anniversary year - positive developments in terms of local sales, productivity and cost management

Bachem Group (SIX: BANB) recorded sales of 145.8 million CHF in the challenging 2011 financial year...

more
07. Mar 2012

Dr. José de Chastonay appointed Chief Marketing Officer of the Bachem Group

Bachem (SIX: BANB) announced today that Dr. José de Chastonay will succeed Dr. Lester Mills as...

more
02. Mar 2012

Bachem and BioSpring agree to collaborate on oligonucleotide-peptide conjugates for R&D

Bachem (SIX: BANB) and BioSpring GmbH today announced that the two companies have concluded an...

more
09. Dec 2011

Bachem expects local sales growth of 6% to 8% in 2011

Today the Bachem Group reduced its expected sales growth rate for the 2011 financial year, from its...

more
04. Nov 2011

Bachem increases working hours at Swiss sites

Bachem Group (SIX: BANB) today announced that it will increase the work time at its operating...

more
02. Nov 2011

Change in Bachem's Corporate Executive Committee

Bachem Group (SIX: BANB) today announced a change in senior management. Dr. Lester Mills, Chief...

more
02. Sep 2011

Passing of the Baton at Bachem Group

Bachem Group (SIX: BANB) today announced top-level management changes that will take effect in...

more
26. Aug 2011

Bachem Shows Strength and Continues the Upswing

Bachem Group (SIX: BANB) performed well during the first semester of 2011 and sustained the upswing...

more
09. Aug 2011

Bachem renews supply contract with AstraZeneca

Bachem today announced the renewal of a supply agreement with AstraZeneca, thereby extending the...

more
29. Jun 2011

Bachem celebrates 40th anniversary

Bachem AG, market leader in peptide-based active pharmaceutical ingredients for the pharma and...

more
10. Jun 2011

Integration of Sochinaz SA completed at mid-year

The plant in Vionnaz will operate as a branch of Bachem AG with the same line of products and...

more
11. Mar 2011

Bachem regains the upswing - significantly improved Business Performance in second semester

The Bachem Group gained significant momentum in the second half of 2010 after a slow start to the...

more
09. Sep 2010

Bachem and Atheris collaborate on Melusine® venom peptide libraries for lead discovery

Bachem today announced that the company concluded an agreement with Atheris Laboratories to market...

more
20. Aug 2010

Difficult start to first half-year of 2010 for the Bachem Group

Positive sales trend thanks to acquisition of projects and recovery of demand. In the first half of...

more
17. Jun 2010

Bachem sells stake in Polyphor to Ingro Finanz AG

Bachem today announced that the company on June 16, 2010, has sold its complete stake in Polyphor...

more
02. Jun 2010

Bachem to supply ISA Pharmaceuticals with finished dosage forms immunotherapeutic HPV-SLP for phase III clinical trials

Bachem and ISA Pharmaceuticals B.V. today announced the conclusion of an agreement for the...

more
19. Mar 2010

Bachem confirms high profitability also in the business year 2009

Bachem today confirms high profitability also in the business year 2009, although North America...

more
14. Aug 2009

Bachem Group Half-Year Results 2009

Compared with the first half of 2008, overall sales are down 7.6% in CHF. The EBIT margin is at...

more
26. May 2009

Stephan Schindler to become new CFO of Bachem Group

Bachem today announced that Stephan Schindler will succeed Michael Hüsler as CFO of the Bachem...

more
23. Apr 2009

Annual General Meeting elects new member of the Board of Directors

Bachem announced today that Dr. Jürgen Brokatzky-Geiger was elected at the Annual General Meeting...

more
31. Mar 2009

Bachem and Debiopharm sign follow-up contract for long-term supply of Triptorelin Pamoate

Bachem and Debiopharm today announced the conclusion of a follow-up agreement for the long-term...

more
13. Mar 2009

Bachem announces financial results for the business year 2008

In the business year 2008, the Bachem Group achieved sales of CHF 195.0 million. Compared with the...

more
17. Sep 2008

Bachem enlarges Corporate Executive Committee

Bachem announced today that Dr. Lester Mills will become the fourth member of the company's...

more
15. Aug 2008

Bachem Group Half-Year Result 2008

Sales of the Bachem Group reached CHF 98.7 million in the first six months of 2008. In local...

more
10. Apr 2008

Action Pharma and Bachem cooperate on AP214 - now ready to enter Phase 2 clinical trials

Action Pharma A/S and Bachem today announced their cooperation on AP214, Action Pharma's lead...

more
14. Mar 2008

Record year for Bachem at all levels in 2007

Sales grow to CHF 198.3 Million - up 17.0% in local currencies and 15.5% in CHF...

more
04. Feb 2008

Bachem production facilities licensed for the manufacture of APIs for the Japanese market

Bachem announced today that the Japanese Ministry of Health, Labour and Welfare has granted the...

more
17. Aug 2007

New record results for Bachem in the first half of 2007

With an increase in sales of 25.4% in CHF or 26.3% in local currencies compared with the first six...

more
09. Aug 2007

Bachem Joint Venture Pevion Biotech Secures CHF 35 Million in Series A Financing Round

Bachem today announced that the company has participated in the first substantial private financing...

more
20. Jun 2007

Bachem renews supply agreement with AstraZeneca

Bachem today announced the renewal of a supply agreement with AstraZeneca. Bachem has supplied...

more
18. Jun 2007

Bachem acquires Clinalfa® from Merck Biosciences

Bachem announced today that, with effect from July 1, 2007, the company is acquiring the business...

more
30. May 2007

Bachem and Intercell agree long-term supply contract for peptide component of vaccine adjuvant IC31

Bachem and Intercell AG today announced the conclusion of a long-term supply agreement for KLK. In...

more
09. May 2007

Neuren and Bachem continue close collaboration on Glypromate® - Neuren's lead product now in phase III

Bachem and Neuren Pharmaceuticals Limited today announced to continue their close collaboration on...

more
16. Mar 2007

Bachem reports record results on 2006 sales and profit

The Bachem Group (SWX: BANB) today announced results for the business year 2006. The company...

more
11. Jan 2007

Bachem and Ardana Sign Long-term Supply Agreement for Aviptadil

Bachem AG and Ardana plc today announced the conclusion of a long-term supply agreement for...

more
18. Aug 2006

Bachem posts sharp rise in profits in the first half of 2006

- Sales growth of 16.3% in CHF and 14.4% in local currencies  - Operating profit and net...

more
27. Jul 2006

Bachem Completes Expansion of Peptide Manufacturing Capacities in the US

The Bachem Group (SWX: BANB) announced today that it has opened its new production unit at its US...

more
07. Apr 2006

Bachem reports record year: highest turnover in the company's history and marked net income growth

- Record sales driven by strong second half and continued dynamic growth of the active ingredients...

more
29. Mar 2006

Bachem Group with new production unit for cytotoxic substances

The Bachem Group announced today that, at the end of 2005, its subsidiary Sochinaz SA completed the...

more
16. Mar 2006

Bachem and Debio conclude long-term supply agreement for triptorelin pamoate

Bachem and Debio conclude long-term supply agreement for triptorelin pamoate. Bachem AG today...

more
09. Mar 2006

Swedish Orphan International and Bachem conclude long-term supply agreement for nitisinone

Bachem AG, Bubendorf, Switzerland and Swedish Orphan International AB, Stockholm, Sweden, today...

more
27. Jan 2006

Bachem 2005 - Strong second half drives record sales.

The Bachem Group (SWX: BANB) recorded its highest sales ever in 2005, totaling CHF 153.7 million....

more